News

Bristol-Myers Squibb, Gilead Sciences to develop, commercialize HIV combo treatment

BY Alaric DeArment

FOSTER CITY, Calif. — Drug makers Bristol-Myers Squibb and Gilead Sciences announced an agreement to develop and commercialize a fixed-dose combination treatment for patients with HIV.

The two companies said the drug will combine Bristol’s Reyataz (atazanavir sulfate) and Gilead’s boosting agent cobicistat, which is designed to increase blood levels of certain HIV medicines to potentially allow for one-pill, once-daily dosing. Gilead is currently studying Reyataz and cobicistat in phase-2 and phase-3 trials.

"This collaboration with Gilead builds on Bristol-Myers Squibb’s long-standing commitment to develop medicines that have the potential to improve meaningful benefit to HIV patients, specifically aiming to enhance treatment options," Bristol EVP, chief scientific officer and president for research and development Elliott Sigal said. "A Reyataz and cobicistat fixed-dose combination has the potential not only to help simplify HIV therapy but also to address an unmet medical need in HIV for additional, innovative treatment options."


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

Rx Jr.: ‘Pharmacy is Right for Me’ spurs youth to pursue pharmacy careers

BY Alaric DeArment

WASHINGTON — With the aging population and the rise in the numbers of people with chronic disease states, the country has a huge need for more pharmacists, so what better place is there to look for them than the nation’s middle and high schools?

The American Pharmacists Association and OptumRx announced Thursday the launch of Pharmacy is Right for Me, an educational initiative designed to encourage students in grades 8 through 12 to pursue careers in pharmacy.

The program is designed to provide students, their families and educators with information and resources about the career opportunities available in the pharmacy field and includes materials on the history of pharmacy, groundbreaking discoveries and the challenges ahead. The centerpiece is an interactive website that includes a self-assessment test, fun facts, career profiles, video testimonials and educational requirements.

"The Pharmacy is Right for Me program is helping to increase young people’s understanding and appreciation of the broad career opportunities that exist within the pharmacy profession," APhA EVP and CEO Thomas Menighan said. "Now more than ever, pharmacists play a vital role in working alongside patients and their healthcare providers to help people better manage their health conditions. Students across the country will require access to needed tools and resource if we wish to continue meeting our nation’s needs and inspire youth to pursue careers as pharmacists."

The website for the program is at Pharmacyforme.org.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

News

UK beauty brand Nip + Fab comes to U.S. via Target partnership

BY Antoinette Alexander

MINNEAPOLIS — Target has partnered with U.K. beauty expert Maria Hatzistefanis and now is carrying her Nip + Fab beauty brand in Target stores and online at Target.com.

Launched in 2010 and previously available only across the pond, Nip + Fab is now available in the United States through its partnership with Target.

Beauty mavens can select from 14 different Nip + Fab skin solutions and body blends, including Nip + Fab Tummy Fix, Nip + Fab Pigmentation Fix and Nip + Fab Dark Circle Fix.

Hatzistefanis also has created the Rodial beauty brand.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES